Ambu A/S (AMBBY)
USD 14.18
(0.0%)
USD 14.18
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 235 Million DKK | 39.88% |
| 2023 | 168 Million DKK | 80.65% |
| 2022 | 93 Million DKK | -62.35% |
| 2021 | 247 Million DKK | 2.49% |
| 2020 | 241 Million DKK | -23.97% |
| 2019 | 317 Million DKK | -5.93% |
| 2018 | 337 Million DKK | 11.96% |
| 2017 | 301 Million DKK | 20.4% |
| 2016 | 250 Million DKK | 64.47% |
| 2015 | 152 Million DKK | 0.66% |
| 2014 | 151 Million DKK | 214.58% |
| 2013 | 48 Million DKK | -58.16% |
| 2012 | 114.71 Million DKK | 65.74% |
| 2011 | 69.21 Million DKK | -17.66% |
| 2010 | 84.05 Million DKK | 50.73% |
| 2009 | 55.76 Million DKK | 11.5% |
| 2008 | 50.01 Million DKK | 16.91% |
| 2007 | 42.77 Million DKK | -11.65% |
| 2006 | 48.41 Million DKK | 28.45% |
| 2005 | 37.69 Million DKK | 13.23% |
| 2004 | 33.28 Million DKK | 27.99% |
| 2003 | 26 Million DKK | 73.55% |
| 2002 | 14.98 Million DKK | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 92 Million DKK | 15.0% |
| 2024 Q3 | 134 Million DKK | -6.94% |
| 2024 Q2 | 144 Million DKK | 56.52% |
| 2023 Q1 | 22 Million DKK | 116.92% |
| 2023 Q4 | 80 Million DKK | 56.86% |
| 2023 Q3 | 51 Million DKK | 240.0% |
| 2023 FY | 168 Million DKK | 80.65% |
| 2023 Q2 | 15 Million DKK | -31.82% |
| 2022 Q2 | 175 Million DKK | 775.0% |
| 2022 Q1 | 20 Million DKK | 2100.0% |
| 2022 Q3 | 28 Million DKK | -84.0% |
| 2022 FY | 93 Million DKK | -62.35% |
| 2022 Q4 | -130 Million DKK | -564.29% |
| 2021 Q2 | 95 Million DKK | 4.4% |
| 2021 Q3 | 62 Million DKK | -34.74% |
| 2021 Q4 | -1 Million DKK | -101.61% |
| 2021 Q1 | 91 Million DKK | 2933.33% |
| 2021 FY | 247 Million DKK | 2.49% |
| 2020 Q4 | 3 Million DKK | -96.74% |
| 2020 Q2 | 104 Million DKK | 147.62% |
| 2020 FY | 241 Million DKK | -23.97% |
| 2020 Q1 | 42 Million DKK | 145.65% |
| 2020 Q3 | 92 Million DKK | -11.54% |
| 2019 Q2 | 130 Million DKK | 106.35% |
| 2019 Q1 | 63 Million DKK | -44.25% |
| 2019 FY | 317 Million DKK | -5.93% |
| 2019 Q4 | -92 Million DKK | -142.59% |
| 2019 Q3 | 216 Million DKK | 66.15% |
| 2018 Q1 | 19 Million DKK | -78.16% |
| 2018 FY | 337 Million DKK | 11.96% |
| 2018 Q2 | 92 Million DKK | 384.21% |
| 2018 Q3 | 113 Million DKK | 22.83% |
| 2018 Q4 | 113 Million DKK | 0.0% |
| 2017 Q2 | 84 Million DKK | 75.0% |
| 2017 FY | 301 Million DKK | 20.4% |
| 2017 Q4 | 87 Million DKK | 6.1% |
| 2017 Q3 | 82 Million DKK | -2.38% |
| 2017 Q1 | 48 Million DKK | -47.83% |
| 2016 Q3 | 75 Million DKK | 44.23% |
| 2016 FY | 250 Million DKK | 64.47% |
| 2016 Q4 | 92 Million DKK | 22.67% |
| 2016 Q1 | 31 Million DKK | -53.03% |
| 2016 Q2 | 52 Million DKK | 67.74% |
| 2015 Q3 | 20 Million DKK | -65.52% |
| 2015 Q4 | 66 Million DKK | 230.0% |
| 2015 FY | 152 Million DKK | 0.66% |
| 2015 Q1 | 8 Million DKK | -90.59% |
| 2015 Q2 | 58 Million DKK | 625.0% |
| 2014 Q3 | 33 Million DKK | 10.0% |
| 2014 Q4 | 85 Million DKK | 157.58% |
| 2014 Q1 | 3 Million DKK | -88.97% |
| 2014 Q2 | 30 Million DKK | 900.0% |
| 2014 FY | 151 Million DKK | 214.58% |
| 2013 Q4 | 27.2 Million DKK | 312.12% |
| 2013 FY | 48 Million DKK | -58.16% |
| 2013 Q3 | 6.6 Million DKK | 200.0% |
| 2013 Q2 | 2.2 Million DKK | -81.51% |
| 2013 Q1 | 11.9 Million DKK | -71.06% |
| 2012 Q4 | 41.11 Million DKK | 71.3% |
| 2012 Q1 | 20 Million DKK | -23.12% |
| 2012 FY | 114.71 Million DKK | 65.74% |
| 2012 Q2 | 29.6 Million DKK | 48.0% |
| 2012 Q3 | 24 Million DKK | -18.92% |
| 2011 Q2 | 1.6 Million DKK | -91.58% |
| 2011 Q1 | 19 Million DKK | -19.68% |
| 2011 Q3 | 22.5 Million DKK | 1306.25% |
| 2011 Q4 | 26.01 Million DKK | 15.61% |
| 2011 FY | 69.21 Million DKK | -17.66% |
| 2010 Q1 | 12.8 Million DKK | 9.74% |
| 2010 Q4 | 23.65 Million DKK | 2.4% |
| 2010 FY | 84.05 Million DKK | 50.73% |
| 2010 Q3 | 23.1 Million DKK | -5.71% |
| 2010 Q2 | 24.5 Million DKK | 91.41% |
| 2009 Q4 | 11.66 Million DKK | -28.44% |
| 2009 FY | 55.76 Million DKK | 11.5% |
| 2009 Q1 | 12.1 Million DKK | 0.0% |
| 2009 Q3 | 16.3 Million DKK | 3.82% |
| 2009 Q2 | 15.7 Million DKK | 29.75% |
| 2008 FY | 50.01 Million DKK | 16.91% |
| 2007 FY | 42.77 Million DKK | -11.65% |
| 2006 FY | 48.41 Million DKK | 28.45% |
| 2005 FY | 37.69 Million DKK | 13.23% |
| 2004 FY | 33.28 Million DKK | 27.99% |
| 2003 FY | 26 Million DKK | 73.55% |
| 2002 FY | 14.98 Million DKK | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AVITA Medical, Inc. | -39.16 Million USD | 699.976% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | 20271.674% |
| Össur hf. | 58.38 Million USD | -302.473% |
| QHSLab, Inc. | -468.36 Thousand USD | 50274.865% |
| Wellstar International, Inc. | -3.1 Million USD | 7659.994% |
| Össur hf. | 58.38 Million USD | -302.473% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | -125.26 Thousand USD | 187708.274% |
| Aurora Spine Corporation | -1.68 Million USD | 14083.409% |
| BrainsWay Ltd. | -4.19 Million USD | 5699.238% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | -722.81 Thousand USD | 32611.912% |
| Hamilton Thorne Ltd. | -607.02 Thousand USD | 38813.589% |
| Vivos Inc. | -2.89 Million USD | 8218.137% |
| Kelyniam Global, Inc. | -218.47 Thousand USD | 107665.764% |
| REMSleep Holdings, Inc. | -1.77 Million USD | 13318.302% |
| Zecotek Photonics Inc. | -3.51 Million USD | 6778.07% |
| Avitar, Inc. | -2.25 Million USD | 10499.937% |
| Nanomix Corporation | -12.33 Million USD | 2005.461% |
| EKF Diagnostics Holdings plc | 2.35 Million USD | -9891.497% |
| Theraclion SA | -3.67 Million USD | 6494.549% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | -1.63 Million USD | 14440.61% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | -2.64 Million USD | 8997.316% |
| Lombard Medical, Inc. | -31.03 Million USD | 857.21% |
| ALR Technologies Inc. | -11.89 Million USD | 2075.344% |
| Stratec SE | 14.42 Million USD | -1529.012% |
| Vycor Medical, Inc. | -69.69 Thousand USD | 337302.795% |
| Heart Tronics, Inc. | -13.32 Million USD | 1863.316% |
| MicroPort Scientific Corporation | -477.62 Million USD | 149.201% |
| VMS Rehab Systems, Inc. | 46.44 USD | -506029185.099% |
| NewCardio, Inc. | -11.49 Million USD | 2144.144% |
| Guided Therapeutics, Inc. | -3.48 Million USD | 6835.454% |
| Ingen Technologies, Inc. | -5.06 Million USD | 4742.909% |
| Odyssey Group International, Inc. | -905.77 Thousand USD | 26044.748% |
| CYduct Diagnostics, Inc. | -418.03 Thousand USD | 56315.658% |
| Wellness Center USA, Inc. | -752.98 Thousand USD | 31309.287% |
| SANUWAVE Health, Inc. | -25.8 Million USD | 1010.606% |
| IR-Med Inc. | -4.9 Million USD | 4887.126% |
| Perimeter Medical Imaging AI, Inc. | -14.03 Million USD | 1774.267% |
| Polarean Imaging plc | -11.88 Million USD | 2077.315% |
| United American Healthcare Corporation | 723 Thousand USD | -32403.458% |
| ECGI Holdings, Inc. | -3.61 Million USD | 6608.084% |
| Nu-Med Plus, Inc. | -125.52 Thousand USD | 187312.211% |
| Capital Group Holdings, Inc. | -658.02 Thousand USD | 35812.983% |
| ADM Tronics Unlimited, Inc. | -716.85 Thousand USD | 32882.266% |
| Medical Supply International USA, Inc. | 394.84 Thousand USD | -59417.779% |
| Urologix, Inc. | -7.6 Million USD | 3188.854% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.69 Million USD | 13974.113% |
| Nexeon MedSystems Inc. | -2.17 Million USD | 10891.494% |
| SS Innovations International, Inc. | -20.94 Million USD | 1222.148% |
| Qualis Innovations, Inc. | -805.02 Thousand USD | 29291.785% |
| Smith & Nephew plc | 263 Million USD | 10.646% |
| NIOX Group Plc | 13.64 Million USD | -1622.814% |
| Fuse Medical, Inc. | 1.45 Million USD | -15996.287% |
| Broncus Holding Corporation | -28.09 Million USD | 936.567% |
| Brain Scientific Inc. | -12.34 Million USD | 2003.781% |
| Pressure BioSciences, Inc. | -29.31 Million USD | 901.657% |
| Health Logic Interactive Inc. | -160.24 Thousand USD | 146747.696% |